HOME >> BIOLOGY >> NEWS
The Origin, Evolution, and Future of Life on Earth

A roundtable discussion
Thursday, December 8, 2005 at 7:30pm
in the Philoctetes Center and Auditorium of The New York Psychoanalytic Institute
247 East 82nd Street, New York, NY 10028

How did life begin? What were its earliest forms? Where did it originate? Was it chance or inevitable? Is a biochemical understanding sufficient to explain creation? How did early molecules evolve into today's humans? What can be said about the development of the mind? What of the phenomenon of consciousness? Can culture, civilization, and technology influence evolution in the future, or will Darwinian rules alone prevail? What dangers lie ahead?

These and other like questions will be examined in this roundtable whose participants come from a wide variety of disciplines: biochemistry, paleontology, philosophy, science and religion. Five prominent scholars discuss these important questions about the past and the future of life on earth.

Participants:

Christian de Duve, 1974 Nobel Prize winner in medicine; author of Singularities (Publication date: September 2005

Colin McGinn, Philosopher (consciousness, intentionality, imagination), author, The Character of Mind; Problems in Philosophy: The Limits of Inquiry

Mark Norell, Curator & Chairman of Paleontology, American Museum of Natural History

Robert Pollack, Professor of Biological Sciences and Director of Columbia University's Center for the Study of Science and Religion

James P. Ferris, Director, New York Center for Studies of the Origin of Life, Rensselaer Polytechnic Institute

This program will take place in the Philoctetes Center, and broadcast through closed circuit television to additional seating in the Auditorium. The event is free and open to the public. Seating is limited on a first come basis.


'"/>

Contact: Ellen Fertig
efertig@nyc.rr.com
212-861-8718
Philoctetes Center for the Multidisciplinary Study of Imagination
17-Nov-2005


Page: 1

Related biology news :

1. Arizona State University hosts Genomes, Evolution, and Bioinformatics conference
2. On life support: Future of science focus of lecture at UH
3. Keck Futures Initiative announces grant recipients
4. The Future of Chemical Plant Security one-day symposium, Monday, Aug. 29
5. National Academies Keck Futures Initiative to co-sponsor life engineering symposium
6. Future diabetes drugs may target new protein interaction
7. Future Vision 2005 to feature innovation in endoscopy
8. What we can learn from the biggest extinction in the history of Earth
9. Chickens also orient themselves by the Earths magnetic field
10. Scientists ponder plant life on extrasolar Earthlike planets
11. NASA-funded robotic sub makes final dive to reach bottom of Earths deepest sinkhole

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The Origin Evolution and Future Life Earth

(Date:2/13/2015)... 2015 ACT Genomics Co., Ltd., a ... transform cancer genomic information into precision diagnosis and ... raised US$ 8 million in the its first private ... Taipei, Taiwan , ACT Genomics has developed ... aim to implement next generation sequencing (NGS) and ...
(Date:2/12/2015)... Conn. , Feb. 12, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... has filed provisional patent 62/113114 for DISTRIBUTED ... DEVICES. The patent further establishes NXT-ID,s position ... its intellectual property portfolio the ability for multiple devices ...
(Date:2/10/2015)... Mass., Feb. 10, 2015  Alere Inc. (NYSE: ... its financial results for the quarter ended December ... Officer and President of Alere said, "We made ... Alere as the global leader in rapid diagnostics ... the Alere Health divestiture in early January enabled ...
Breaking Biology News(10 mins):ACT Genomics Raises $8 Million in its First Private Funding Round 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33
(Date:2/27/2015)... 27, 2015 Immunovaccine Inc. (“Immunovaccine” or ... a fraudulent press release disseminated this morning by PR ... Immunovaccine. This press release states that Immunovaccine has entered ... The press release did not originate from Immunovaccine and ... the press release. Please note that all official ...
(Date:2/27/2015)... Scotia (PRWEB) February 27, 2015 ... vaccine and immunotherapy company, today announced that the ... application for Fast Track designation and Phase I ... in conjunction with the mutual co-development agreement signed ... obtained Fast Track designation for the DPX-Survivac. , ...
(Date:2/27/2015)... CA (PRWEB) February 27, 2015 Cytokinetics, ... forces on February 28 with patients and health care ... awareness for Rare Disease Day®. Rare Disease Day ... and calling attention to the special challenges faced by ... them. , “Cytokinetics is proud to stand alongside patients ...
(Date:2/26/2015)... 2015  23andMe, the leading personal genetics company, today ... Privacy Officer and Corporate Counsel. Black brings a strong ... well as health care regulations. As a member of ... for reviewing, updating and enhancing the company,s privacy and ... She joined the company January 5, 2015 and reports ...
Breaking Biology Technology:Immunovaccine Disclaims Hoax Press Release 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 623andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2
Cached News: